Treatment with the <X2-adrenergic antagonist idazoxan (IDA) can provide protection from global cere bral ischemia. However, IDA also recognizes another class of receptors, termed imidazole (1M) receptors, which differ from <x2-adrenergic receptors and are respon sible for the hypotensive actions of some centrally acting agents such as the oxazole rilmenidine (RIL). We there fore sought to determine whether RIL, an agent highly selective for 1M receptors, offered protection from focal cerebral ischemia elicited in rat by ligation of the middle cerebral artery (MCA). We compared the effects of RIL with the effects of IDA and the selective non-1M <x2antagonist SKF 86466 (SKF). In addition, we examined whether the neuroprotective effects of RIL and IDA could be attributed to changes in local CBF (LCBF). The MCA was occluded and animals either received immedi-
It has been proposed that stimulation of adrener gic receptors in brain may offer protection from neuronal damage associated with cerebral ischemia (Koide et aI., 1986; Wieloch et aI., 1986) . In partial support of the hypothesis are the findings that treat ment with the drug idazoxan {2-[2-(1,4-benzo dioxanyl)]-2-imidazoline HCI; IDA}, an agent usu ally considered to be an <X2-adrenergic antagonist, reduces the magnitude of the delayed neuronal de generation elicited by global cerebral ischemia (Ya suda et aI., 1978; Gustafson et aI., 1989 Gustafson et aI., , 1990 .
However, over the last several years, evidence has accrued to indicate that IDA also recognizes ate administration of drug while arterial pressure was maintained for 1 h or had local CBF increased to 200% of control for 1 h by hypercapnia or hypertension. RIL elic ited a significant dose-dependent preservation of tissue to 33% of control at optimal dose (0.75 mg/kg). IDA (3 mg/ kg) significantly reduced the size of ischemic infarction by 22%. In contrast, SKF (15 mg/kg) as well as doubling of LCBF did not preserve ischemic tissue. We conclude that both RIL and IDA can reduce focal ischemic infarc tion but that the mechanism does not appear secondary to antagonism of <x2-adrenergic receptors or elevation of LCBF. Occupation of 1M receptors, either in the isch emic zone or at remote brain sites, may be responsible for neuroprotection of RIL and IDA. Key Words: Adrenergic receptor-Focal cerebral ischemia-Idazoxan Imidazole receptor-Rilmenidine.
another class of receptors that bind substituted im idazolines such as clonidine and its congeners (Michel et aI., 1989) . These receptors, termed im idazole (1 M), 1M-preferring or imidazoline guanidinium receptors (Ernsberger et aI., 1987; Coupry et aI., 1989; Lehmann, 1989) , differ from the <X2-adrenergic receptors with respect to anatom ical distribution in brain and periphery (Ernsberger et aI., 1987; Bricca et aI., 1989b; Michel et aI., 1989; Wickberg and Uhlen, 1990) , in signal transduction mechanisms (Ernsberger et aI., 1988a; Regunathan et aI., 1990) , and in their very distinct binding pro files, which exclude native adrenergic ligands such as norepinephrine (Ernsberger et aI., 1987 (Ernsberger et aI., , 1988a . Whether IDA acts as an agonist or antagonist at 1M receptors is not known. Conceivably the neuropro tective actions of IDA may relate more to its inter actions with 1M than with <X2-adrenergic receptors in brain.
In the present study we have therefore examined the neuroprotective effects of an agent with high selectivity for 1M receptors, the oxazole rilmeni dine [2-(dicyclopropylmethyl) amino-2-oxazoline phosphate; RIL] (Gomez et aI., 199 1) . We sought to determine whether the agent offered protection against focal cerebral ischemia elicited in rat by li gation of the middle cerebral artery (MCA), if so whether the effect was mimicked by IDA, which has yet to be tested against focal ischemia, and fi nally whether any neuroprotective effects of the agent can be attributed to changes in local CBF (LCBF) . We demonstrate that RIL elicits a dose dependent reduction in the size of the focal isch emic infarction produced by occlusion of the MCA in rat, that the effect is mimicked by IDA, but that administration of the highly selective !X2-adrenergic antagonist SKF 86466 (SKF) or increasing LCBF by 200% will not reduce the size of infarction. The results suggest that the neuroprotective effects of RIL and IDA may relate to occupation of 1M recep tors.
METHODS
Methods for production of focal cerebral infarction by occlusion of the MCA, for computation of infarct volume, and for recording of LCBF by laser-Doppler flowmetry (LDF) have been described in detail in prior publications Reis et aI., 1991) and will only be summarized here.
General procedures
Studies were performed on 55 adult male Wi star-Kyoto rats of the spontaneously hypertensive strain (SHR) weighing 280--370 g. SHRs were selected because of the uniformity of lesions elicited between animals (Brint et aI., 1988; Reis et aI., 1991) . Animals were maintained in a 20°C enviroment and fed laboratory chow ad libitum. They were anesthetized with isoflurane (1-3% in 100% O2) blown over the nose. Thin-wall polyethylene (l.3-mm OD) catheters were placed in the right femoral artery and vein. The arterial catheter was connected to a Statham P23 db transducer for continuous monitoring of arterial pressure and heart rate on a chart recorder (Beckman model R6 11). The venous catheter was employed for drug administration.
Following instrumentation, rats were mounted in a Kopf stereotaxic apparatus and maintained within 37-38°C by a thermostatically controlled infrared lamp con nected to a rectal probe. Blood (0.2 ml) was withdrawn from the arterial catheter for determination of pH, Po2, and Peo2 by a blood gas analyzer (Ciba-Corning model 178) and for calculation of hematocrit. Throughout the duration of the experiment, which required 3 h, the ani mals remained in an anesthetized state with isoflurane.
The MCA was exposed for occlusion distal to the len ticulostriatal branches by a method modified from that of Tamura et al. (1981) . Animals were rotated in the stereo taxic frame to a lateral position with the right side facing upward. The skin was incised midway between the orbit and external auditory meatus and the temporal muscle retracted. Under magnification, the MCA was exposed through a hole in the skull at a point rostral to the fusion J Cereb Blood Flow Metab, Vol, 12, No.1, 1992 of the zygomatic arch and squamous bone made with a dental drill continuously cooled with a saline drip. The dura overlying the MCA was incised. A small wire hook was inserted under the MCA just superior to the inferior cortical vein and the artery was subsequently cauterized.
Immediately following MCA occlusion, drug was ad ministered intravenously with arterial pressure main tained in the control range, if necessary, with phenyleph rine. After 1 h, the cranial wound was covered with gel foam and closed with sutures. Wounds were treated with I % lidocaine and Bacitracin ointment. The femoral artery and venous catheters were capped, the animal was re moved from the stereotaxic frame, anesthesia was dis continued, and the animal was returned to its cage.
Twenty-four hours later, animals were reanesthetized with isoflurane and killed by decapitation. The brains were removed and placed in liquid Freon at -20°C. Brains were serially sectioned at 20 f.Lm on a cryostat microtome, at -20°C, in the coronal plane. Sample sec tions were obtained every 200 f.Lm and stained by the Nissl method.
Each section was identified by reference to corre sponding levels in an atlas of the rat brain (Paxinos and Watson, 1986) . Microscopically, ischemic nerve damage was characterized by loss of Nissl bodies, cell body re traction, and hyperchromasia of the cell nucleus. Every third brain section (600 f.Lm) was projected on a data tablet from an overhead projector. The area of infarction was computed by tracing the lesion corresponding to the loss of Nissl substance on a Jandel Scientific Sigma Scan. The volume of the infarct was computed as the product of the cross-sectional area (mm 2 ) for all sections and the dis tance between sections, and then plotted as a function of the distance from the interaural line.
In some experiments LCBF was increased diffusely to assess the effects of elevated LCBF on the size of the infarction. LCBF was increased in two ways: by elevat ing MABP above the autoregulated range for SHRs (Barry et aI., 1982) with infusion of phenylephrine or by hypercapnia. Changes in LCBF were monitored contra lateral to the site of MCA occlusion by LDF, which per mits continuous recording of LCBF in vivo (Dirnagl et aI., 1989) . Hypercapnia was induced by administering 5% CO2 with 100% O2 and phenykphrine was used to induce hypertension. Elevated CBF was maintained for 1 h. Fol lowing this period, wounds were closed and aseptically treated with lidocaine 1% and Bacitracin; CO2 or phen ylephrine administration was discontinued and the ani mals were returned to their cages.
In studies in which LCBF was measured, LDF was performed with a PeriFlux PF3 (Perimed) flowmeter with flow values expressed as perfusion units and changes in LCBF expressed as percentage change in flow. A hole 1 mm in diameter was drilled through the parietal bone 2.0 mm lateral and 2.5 mm caudal to the bregma just prior to ligation of the MCA. The dura was left intact. Following the application of mineral oil to the hole, the probe (dental probe, model PF 316) was positioned -0.5 mm above the dural surface. Care was taken to avoid bleeding from the bone or dura as well as exposure of the probe to direct light since these can reduce the flow signal. At times, it was necessary to reposition the probe 0.3 mm rostraUy or caudally to avoid placement over large pial vessels (>500 f.Lm), which invalidate the LDF flow signal (Haberl et aI., 1989) . The analog output from the LDF was displayed on a polygraph (Beckman model R6 11). A time constant of 3 s was employed to avoid pulsatile variations in flow sig nal.
Studies were conducted in groups with n = 5 rats. The groups consisted of (a) rats in which only the MCA was occluded (MCA control); (b) rats receiving intravenous drugs RIL (0.05, 0.25, 0. 50, 0.75, 1.0, and 2.0 mg/kg), IDA (3 mg/kg), or SKF (15 mg/kg); (c) rats in which LCBF was increased by hypercapnia or hypertension. MABP, arterial blood gases, and hematocrit did not differ between groups (except for MABP and Peoz in hyperten sive or CO2-treated rats) (see Table 2 ). Each animal group underwent treatment as a discrete entity. Subsequent in farct volume computation was randomly ordered among the animal groups. Physiological variables, LCBF, infarct cross-sectional area, and infarct volume are expressed as means ± SD. Comparisons of infarct volume as well as physiological parameters among groups were assessed using the analysis of variance and the Newman-Keuls test. Differences were considered significant for p < 0.05.
RESULTS

MeA occlusion in control animals
Occlusion of the MeA in the control group (n = 5) resulted in a well-defined infarction within the vascular territory perfused by the MeA in rat ( Fig.  1) . When expressed as an area of infarction along the rostrocaudal plane, the lesion began at the tem poral cortex (3.75 mm anterior to the interaural line) and extended to the frontal and angular insular cor tex (14.25 mm anterior to the interaural line) for a total of 10.5 mm ( Fig. 1 ). Laterally the lesion in volved large portions of the parietal, granular insu lar, angular insular, pyriform, perirhinal, and tem poral cortices (Fig. 2) . Medially, the infarct in volved the lateral caudate and putamen, portions of the hippocampal formation, and the dorsal portion of the amygdala (Fig. 2) . The lesions were remark ably similar between animals as demonstrated by the uniform distribution and small variability among the cross-sectional areas at comparable sites (Fig.  1 ). The maximal cross-sectional area of the infarct was 31.65 ± 2.6 1 mm 2 at 8.0 mm anterior to the interaural line. The average volume was 196.3 1 ± 14.86 mm3 ( Table I) .
Effects of RIL on focal ischemia
The MeA was occluded in five animals immedi ately followed by administration of a bolus of RIL (1 mg/kg i. v.). This dose of RIL is at the upper end of the dose-response curve for the hypotensive ac tions of the drug and, as reported elsewhere (Go mez et aI., 199 1), lowers MABP by �45 mm Hg with a maximum response occurring in 15 min in rats of the Sprague-Dawley strain. To counteract the hypotension, MABP was maintained in the con trol range by a variable infusion of phenylephrine (0.5-6.5 fLg/min) beginning at the time of RIL ad- 15.0 mg/kg; n = 5). Maximal cross-sectional area of infarc tion was 8.0 mm anterior to the interaural line in the control and SKF groups. In contrast, preservation of ischemic tissue following treatment with either RIL or IDA was confined to the caudal portions of the leSion (maximum cross-sectional area of infarction 10.0 mm anterior to the interaural line).
ministration and maintained for the 1 h following vascular occlusion. MABP did not vary from con trol following completion of phenylephrine treat ment (Table 2) . RIL at this dose reduced the size of the infarction elicited by MeA occlusion (Fig. 1; Table 1 ). While the rostrocaudal extent of the lesion was compara ble between treated and untreated rats (Fig. 1) , the cross-sectional area of infarction was reduced in the caudal two-thirds of the infarction. The maximum cross-sectional area was 22. 12 ± 2.94 mm 2 , or �60% of control, and located 10.0 mm anterior to the interaural line (Fig. 1) . The volume of the infarct was reduced by � 29% as compared with controls (Table 1) .
Representative serial coronal sections of distribution of ischemic infarct produced by middle cerebral artery (MCA) occlusion in con trol (n = 5) , rilmenidine-treated (1. 0 mg/kg; n = 5) , and idazoxan-treated (3. 0 mg/kg; n = 5) an imals. The dark region represents infarct area 24 h following MCA occlusion for each group. When compared with control, areas of preser vation by either rilmenidine or idazoxan treat ment included the hippocampal formation, perirhinal cortex, ventral and dorsal portions of the parietal cortex, temporal cortex, frontal cor tex, as well as medial portions of the caudate and putamen.
CONTROL RILMENIDINE IDAZOXAN
The distribution of the lesion involved the pari etal cortex, granular insular cortex, angular insular cortex, caudate-putamen, and pyriform cortex (Fig.  2 ). Areas of preservation, when compared with con trol, included the hippocampal formation, amyg dala, perirhinal cortex, ventral and dorsal portions of the parietal cortex, granular insular cortex, angu-lar insular cortex, temporal cortex, and frontal cor tex. In addition, medial portions of the caudate and putamen were spared.
Dose response of RIL
To determine whether the neuroprotective ac tions of RIL were dose dependent, RIL was admin- Parameters were not significantly different among animal groups except in the hypercapnic group with Peo2 = 66.2 ± 8.2 mm Hg and the hypertensive group with MABP = 189 ± 9 mm Hg. n = 5 for all groups.
a Difference from control (p < 0.05).
istered in different doses (0.05, 0.25, 0.5, 0.75, and 2 mg/kg) to groups of five rats immediately follow ing MeA occlusion. RIL at 0.05 and 0.25 mg/kg did not alter MABP. At 0.5, 0.75, and 2 mg/kg the hy potensive effects were progressively greater, re quiring larger doses of phenylephrine (0.5-10.0 j.Lg/ min) to maintain MABP in the control range during the 1 h following administration of RIL. Upon com pletion of phenylephrine, MABP returned to con trol levels except in the 2-mg/kg group. In this group, MABP was reduced to -75 mm Hg, a 50% drop in MABP from control at the time the animals were returned to their cages. The magnitude of neuroprotection elicited by RIL was dose related (Fig. 3, left) . RIL at 0.05 and 0.25 mg/kg had no effect upon the distribution and magnitude of the infarction produced by MeA oc clusion (Table 1 ). RIL at 0.5 mg/kg insignificantly reduced infarction volume by -10% (Table 1) . However, RIL at 0.75 mg/kg significantly reduced infarct volume (p < 0.05) by -33% (Table 1 ). The volume of preservation was not increased with RIL 1.0 mg/kg ( Fig. 3; Table 1 ).
Interestingly, the size of the infarct was signifi cantly increased by 19% with RIL at 2.0 mg/kg ( Fig.  3 ; Table 1 ). As in the control group, the lesion in volved the frontal cortex, angular insular cortex, parietal cortex, piriform cortex, granular insular cortex, perirhinal cortex, portions of the hippocam pal formation, and the caudate-putamen. However, the infarct also extended rostrally to the orbital cor tex, medially to the corpus callosum and significant portions of the caudate-putamen, and caudally to the occipital cortex. The increase in infarct size may be secondary to the associated hypotension. Irrespective of cause, this finding indicates that the infarction produced by MeA occlusion in the rat is not at a "ceiling" and is capable of being enlarged.
Effects of IDA on focal ischemia
IDA (3 mg/kg) was administered by bolus intra venous injection to five rats immediately following MeA occlusion with blood pressure maintained by phenylephrine (0.5-6.5 j.Lg/min) ( Table 2 ). This amount of IDA is comparable with the dose used with prolonged infusion of IDA that has been shown to reduce the neuronal necrosis elicited by global cerebral infarction in rat (Gustafson et aI., 1989) . After 1 h and at the termination of the infusion of phenylephrine, MABP did not differ from control.
IDA, like RIL, significantly reduced the size of the infarction (Fig. 1) . In the IDA group, the reduc tion of the lesion produced by MeA occlusion was comparable in distribution to that produced by the optimal dose of RIL, with the maximal area of sal vage occurring in the caudal two-thirds of the lesion (Figs. 1 and 2) . Although the magnitude of the re duction was 22% of control, this was slightly but not significantly less than the 33% salvage seen with RIL ( Table 1) .
Effects of SKF
The selective u2-adrenergic antagonist SKF (Hie ble et aI., 1986) was administered intravenously as a bolus (15 mg/kg) immediately following occlusion of the MeA. Phenylephrine (0.5-6.5 j.Lg/min) was ad ministered following the bolus for 1 h to maintain MABP in the control range. MABP did not differ from control following discontinuation of phenyl ephrine (Table 2) . SKF had no effect upon the size or distribution of the infarction elicited by MeA occlusion (Fig. 1; Table 1 ).
Since SKF alone did not alter infarct size, the Effect of RIL dose on distribution of isch emic infarct 24 h after occlusion of middle cerebral artery. Cross-sectional area of in farct (mm 2 ) was measured at progressive dis tances (mm) from the interaural line in con trol animals (n = 5) and animals treated with RIL (0.75 mg/kg, n = 5); 1. 0 mg/kg, n =5; 2.0 mg/kg, n = 5). Infarct area following admin istration of RIL 0.75 and 1. 0 mg/kg was re duced in the caudal portion of the lesion. In contrast, administration of RIL 2.0 mg/kg in creased infarct area in caudal as well as ros tral portions of the lesion. ability of IDA to reduce focal ischemia does not appear to be secondary to <X2-receptor antagonism.
In an attempt to further define the mechanism of IDA's ability to salvage ischemic tissue, IDA (3 mg/ kg) and SKF (15 mg/kg) were administered concur rently via intravenous bolus under the present ex perimental protocol. Although phenylephrine (4.5-11.5 J..L g/min) was able to counteract the hypotension from these agents during the 1-h protocol, animals did not survive the ensuing 24 h secondary to persistent hypotension (MABP 40 mm Hg).
Effects of elevating CBF
To assess whether the protective actions of RIL or IDA might relate to increasing CBF in the terri tory of tissue salvage, a region in which others have shown LCBF is substantially reduced (Dirnagl and Pulsinelli, 1990) , LCBF was increased for the 1 h following occlusion of the MCA. LCBF was ele vated in groups of five rats by either hypercapnia or hypertension. Changes in LCBF were monitored by LDF through a probe placed over the parietal cor tex contralateral to MCA occlusion. Following MCA occlusion, animals in the hypercapnia group were ventilated with 5% CO2 in 100% O2, which elevated the Pco2 to 66 mm Hg (Fig. 4, left ; Table  2 ). LCBF rose immediately and was sustained for the hour at 197 ± 4% of control. The hypertension group received phenylephrine (0,5-2.0 J..L g/min) for 1 h following MCA occlusion, which elevated LCBF to 197 ± 4% of control and MABP to -190 mm Hg, well above the upper limit of autoregulation in the SHR (Barry et aI., 1982) (Fig. 4, left ; Table 2 ). LCBF elevated by hypercapnia did not alter in farct distribution or size. The MCA lesion of the hypercapnic group paralleled that of the control Cross-sectional area of infarct (mm 2 ) was measured along the rostro caudal axis from the interaural line in control animals (n = 5) and animals with CBF elevated to 200% of control by either hypercapnia (n = 5) or hypertension (n = 5). Note that both methods of increased CBF failed to alter size or distribution of lesion.
group, extending 10.5 mm from the frontal pole to the temporal cortex. The maximum cross-sectional area of infarction was 36.98 ± 6.72 mm 2 and oc curred �9.0 mm anterior to the interaural line as in the control group (Fig. 4, right) . The average infarct volume of the hypercapnic group was 20 1.34 ± 45.54 mm3 and did not differ significantly from the average infarct volume of the control group (196.31 ± 14.86 mm3) (Table O. Elevation on LCBF by hypertension also did not affect infarct distribution or size. Similar to the con trol group, the MCA lesion of the hypertensive group extended 10.5 mm from the frontal pole to the temporal cortex. The maximum cross-sectional area of infarction was 32.71 ± 6.95 mm 2 and oc curred 9.0 mm anterior to the interaural line (Fig. 4,  right) . The average infarct volume of 203.96 ± 35. 10 mm3 in the hypertensive group was not significantly different from the infarct volume of 196.31 ± 14.86 mm3 in the control group (Table O .
DISCUSSION
Our results demonstrate that RIL and IDA can partially reduce the size of focal cerebral ischemic infarctions elicited by occlusion of the MCA in rat. RIL elicited a maximal reduction of �33%, which was dose dependent. IDA also was protective but less effective, providing only a 22% reduction in lesion size. However, this finding demonstrates that IDA is effective as a neuroprotective agent not only in global (Gustafson et aI., 1989) but also in focal cerebral ischemia.
The neuroprotective effects of IDA and RIL do not appear to be secondary to variations in blood gases, hematocrit, or MABP or to the use of iso flurane as an anesthetic. The control and drug groups did not experience differences in ventilatory or hemodynamic function. Partial pressures for O2 and CO2 as well as values for pH and hematocrit did not differ significantly among the groups except when Peo2 or MABP was deliberately elevated. In addition, hematocrit was maintained above the level at which hemodilution has been reported to reduce ischemic damage (Tu et aI., 1988) . Although IDA, RIL, and SKF all reduced MABP upon ad ministration, MABP was maintained within the con trol range for the 1 h following occlusion of the MCA and then discontinued before cessation of the anesthesia. Following discontinuation of phenyl ephrine, however, the MABP for all groups, with one exception, returned to the control range. Thus, MABP cannot be considered a relevant variable. The exception comprised animals treated with the highest dose of RIL, 2 mg/kg. These animals were hypotensive at the termination of the 1 h following drug administration, which, as others have demon strated (Cole et aI., 1990) , probably contributed to the enlargement of the lesion relative to that of the control group. Isoflurane administration is known to reduce infarct size during periods of focal cere bral ischemia (Baughman et aI., 1990) . Although we did not study the isolated role of isoflurane on the volume of cerebral infarction, control as well as drug treatment groups received identical doses of the anesthetic. Therefore, reductions in infarct vol ume following drug administration can be attributed to the neuroprotective effects of IDA and RIL.
The area of salvage provided by RIL and IDA included lesions of dorsal and ventral parietal cor tex, temporal cortex, perirhinal cortex, pyriform cortex, lateral caudate-putamen, and dorsal frontal cortex. Preservation was more prominent in the caudal region of the hemisphere. In general, the area of salvage was comparable with that obtained by others in this focal ischemic model in rat using other cerebral protective agents such as calcium channel or N-methyl-D-aspartate antagonists (Ro man et aI., 1989; lacewicz et aI., 1990) . This area most likely corresponds to the penumbral zone (As trup et aI., 198 1) characterized by partial reduction in LCBF and patchy elevations in regional cerebral glucose utilization (Nedergaard et aI., 1986) and may represent those regions of brain accessible to collateral flow.
The pharmacological basis of the neuroprotection afforded by RIL and IDA is not obvious. In recent series of studies, Gustafson et al. (1989 Gustafson et al. ( , 1990 have suggested that the mechanism of IDA in protecting against neuronal death initiated by global ischemia J Cereb Blood Flow Me/ab. Vol. 12. No.1. 1992 relates to the action of the drug as an u2-adrenergic antagonist. They propose that IDA, by presynapti cally facilitating the release of noradrenaline from nerve endings in brain (Dennis et aI., 1987) and/or, as others have demonstrated, by increasing the ac tivity of noradrenergic neurons of the locus cerule us (Simson and Weiss, 1987) , enhances the accu mulation of noradrenaline, which functions to pre serve ischemic tissue. In addition, they note that reduction of the release of noradrenaline in the brain, either pharmacologically or by lesions of the locus ceruleus, enhances the neuronal damage pro duced by seizures or global ischemia (Blomqvist et aI., 1985; Nevander et aI., 1986 ), a position not en tirely supported by other studies, which suggest the opposite (Welch et aI., 1975; Fridovich, 1978) .
However, it is difficult to reconcile their interpre tation with our findings that RIL offers even greater protection than IDA. Unlike IDA, RIL is in part an u2-adrenergic agonist. It reduces the release of nor adrenaline prejunctionally in the periphery (Ver beuren et aI., 1986; Li and Rand, 1988) and de creases the firing of locus ceruleus neurons (Dresse et aI., 1988) . Thus, with respect to the u2-adrenergic receptor, the actions of RIL are opposite to those of IDA. Moreover, the fact that the selective U2adrenergic antagonist SKF (Hieble et aI., 1986) had no effect upon the size of the infarction also argues against the theory that IDA reduces the size of isch emic infarctions by an action as an u2-adrenergic antagonist. An alternative interpretation is that both RIL and IDA afford protection against ischemic in farctions by an interaction with a novel class of re ceptors that recognize a number of agents with an 1M structure, the 1M receptors.
The concept of the 1M receptor arose from the recognition that the central hypotensive actions of clonidine and other 'centrally acting hypotensive agents appeared, on the basis of structure-function analysis, to relate more to their structure as substi tuted IMs than to their purported actions as U2adrenergic agonists (Bousquet et aI., 1984; Erns berger et aI., 1987) . This fact has been proved by ligand binding studies, which have demonstrated that clonidine and congeners bind not only to U2adrenergic binding sites but to a distinct membrane site recognizing IMs including IDA, some oxazoles such as RIL, some alkaloids such as yohimbine, and some guanidinium compounds. Binding at these sites is saturable with high affinity, stereospecific, and not displaced by substituted phenylethylamines such as the catecholamines (Meeley et aI., 1986; Ernsberger et aI., 1987; Michel et aI., 1989; Parini et aI., 1989) . Nor is the 1M receptor a histamine re ceptor (Ernsberger et aI., 1987) , even though hista-mine is the principal bioactive endogenously syn thesized 1M. That the 1M a2-adrenergic receptors are in fact distinct entities has been demonstrated by the findings that they have a different topo graphic distribution in brain and kidney (Ernsberger et aI., 1987; Bricca et aI., 1989a; Ernsberger et aI., 1990) , that they may be expressed in different cell lines (Feinland et aI., 1988; Ernsberger et aI., 1989) , and that their signal transduction mechanisms differ (Ernsberger et aI., 1988a; Regunathan et aI., 1990) .
Within this context is the fact that IDA and RIL bind to 1M as well as to a2-adrenergic receptors (Bricca et aI., 1989a; Gomez et aI., 199 1) but that their actions at the latter differ. Whether the agents act as complete or partial agonists or antagonists at these sites is not known. However, the demonstra tion here that IDA and RIL, with opposite actions on a2-adrenergic receptors, share common neuro protective actions suggests that the commonality of pharmacological mechanisms is an interaction with 1M rather than with adrenergic receptors.
The mechanism by which IDA and RIL may en hance protection from focal ischemia is not known. Two broadly defined mechanisms should be consid ered. The first, a direct action, would involve agents acting within the target to provide protec tion. The second, an indirect action, would invoke 1M receptor binding at a site remote from the target, which may influence the size of the infarction by a trans neuronal pathway.
The direct actions of RIL and IDA in the target area could be via an enhancement of LCBF. Yet, it does not seem probable that the neuroprotective effects of IDA and RIL can be attributed solely to elevations in LCBF, conceivably related to actions of the agents upon extracerebral or pial vessels (Be van et aI., 1987) . Doubling of LCBF in the normal hemisphere by hypercapnia or hypertension for 1 h following MCA occlusion did not alter the distribu tion or size of the infarction produced by MCA oc clusion. While changes within the penumbra were not measured, it is probable that the flow changes would be enhanced, since autoregulation is partially impaired in that zone (Dirnagl and Pulsinelli, 1990) . The failure of elevations of LCBF to modify the magnitude of the infarction is in accord with the conclusions of some (Fenske et aI., 1975; Bleyarert et aI., 1980) but not all (Hayashi et aI., 1984; Drum mond et aI., 1988 ) that elevating LCBF does not afford protection from focal ischemia.
Another possibility is that the agents might act directly upon neurons in the salvageable zone within the penumbra to protect them from cytotoxic ionic and/or metabolic events as is believed to be the mechanism of N-methyl-D-aspartate receptor antagonists. However, it should be noted that bind ing studies have demonstrated that 1M receptors are sparse in the bovine, rat, and human cerebral cortex (Ernsberger et aI., 1987; Bricca et aI., 1988 Bricca et aI., , 1989b in contrast to the brainstem where, at least in bo vine brain, 30% of binding sites for clonidine are of the 1M receptor subclass (Ernsberger et aI., 1988b) . Thus, the paucity oflM receptors within the cortex makes a direct cytoprotective action of the agents an unlikely mechanism, recognizing the absence of in vitro studies with respect to neuroprotection by RIL or IDA.
Conceivably the action of RIL and/or IDA could be indirect, in which the agents would act on neu rons elsewhere in the brain to exert a neuroprotec tive effect on ischemic neurons over intrinsic path ways. In this scenario, activation (or inhibition) of the pathway would result in release of other trans mitters in the target, which would be the neuropro tective moieties. The feasibility of this mechanism derives from recent studies demonstrating that elec trical stimulation of the cerebellar fastigial nucleus can reduce infarct volume by 40% following MCA occlusion (Berger et aI., 1990; Reis et aI., 199 1) . Since the cerebrovascular effects of fastigial nu cleus stimulation can be inhibited by bilateral le sions of the rostral ventrolateral medulla (Chida et aI., 1990) , a site rich in 1M receptors (Bricca et aI., 1988 (Bricca et aI., , 1989b Ernsberger et aI., 1988; Gomez et aI., 199 1) , this area might be one site of action of the drug.
In conclusion, we have demonstrated that IDA and RIL significantly reduce the size of focal isch emic infarction elicited by MCA occlusion in rat. The effect cannot be attributed to a2-antagonism by IDA, nor is it likely to be a consequence of the a2-adrenergic agonism of RIL. Since IDA and RIL both bind to 1M receptors, it is conceivable that occupation of these sites may be responsible for the neuroprotection of both agents. It is unknown whether the effects are due to direct actions of these agents on ischemic neurons in the target or indirect activation of neural networks that transneuronally modify cerebral ischemic injury.
